參考文獻
[1]Balkrishnan, R. (1998). Predictors of medication adherence in the elderly. Clinical therapeutics, 20(4), 764-771.
[2]Benner, J. S., Glynn, R. J., Mogun, H., Neumann, P. J., Weinstein, M. C., & Avorn, J. (2002). Long-term persistence in use of statin therapy in elderly patients. Jama, 288(4), 455-461.
[3]Claxton, A. J., Cramer, J., & Pierce, C. (2001). A systematic review of the associations between dose regimens and medication compliance. Clinical therapeutics, 23(8), 1296-1310.
[4]Desselle, S., Zgarrick, D., & Alston, G. (2016). Pharmacy Management: Essentials for all practice settings: McGraw Hill Professional.
[5]Foxall, G. (2005). Understanding consumer choice: Springer.
[6]Golin, C. E., Liu, H., Hays, R. D., Miller, L. G., Beck, C. K., Ickovics, J., . . . Wenger, N. S. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of general internal medicine, 17(10), 756-765.
[7]Haynes, R. B., McDonald, H. P., & Garg, A. X. (2002). Helping patients follow prescribed treatment: clinical applications. Jama, 288(22), 2880-2883.
[8]Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009). Medication adherence: its importance in cardiovascular outcomes. Circulation, 119(23), 3028-3035. doi:10.1161/CIRCULATIONAHA.108.768986
[9]Kuester, S. (2012). MKT 301: Strategic marketing & marketing in specific industry contexts. University of Mannheim, 110, 393-404.
[10]LaRosa, J. C. (2000). Poor compliance: the hidden risk factor. Current Atherosclerosis Reports, 2(1), 1-4.
[11]McCaffrey, D., Smith, M., Banahan, B., Frate, D., & Gilbert, F. (1998). A continued look into the financial implications of initial noncompliance in community pharmacies: an unclaimed prescription audit pilot. JOURNAL OF RESEARCH IN PHARMACEUTICAL ECONOMICS, 9, 33-58.
[12]Murphy, D. A., Sarr, M., Durako, S. J., Moscicki, A.-B., Wilson, C. M., & Muenz, L. R. (2003). Barriers to HAART adherence among human immunodeficiency virus–infected adolescents. Archives of pediatrics & adolescent medicine, 157(3), 249-255.
[13]Murray, P. W., Agard, B., & Barajas, M. A. (2015). Forecasting supply chain demand by clustering customers. IFAC-PapersOnLine, 48(3), 1834-1839.
[14]Nikolopoulos, K., Buxton, S., Khammash, M., & Stern, P. (2016). Forecasting branded and generic pharmaceuticals. International Journal of Forecasting, 32(2), 344-357. doi:10.1016/j.ijforecast.2015.08.001
[15]Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353(5), 487-497.
[16]Quilumba, F. L., Lee, W.-J., Huang, H., Wang, D. Y., & Szabados, R. L. (2015). Using smart meter data to improve the accuracy of intraday load forecasting considering customer behavior similarities. IEEE Transactions on Smart Grid, 6(2), 911-918.
[17]Senst, B. L., Achusim, L. E., Genest, R. P., Cosentino, L. A., Ford, C. C., Little, J. A., . . . Bates, D. W. (2001). Practical approach to determining costs and frequency of adverse drug events in a health care network. American Journal of Health-System Pharmacy, 58(12), 1126-1132.
[18]Steiner, J. F., & Prochazka, A. V. (1997). The assessment of refill compliance using pharmacy records: methods, validity, and applications. Journal of clinical epidemiology, 50(1), 105-116.
[19]Wilson, J., Axelsen, K., & Tang, S. (2005). Medicaid prescription drug access restrictions: exploring the effect on patient persistence with hypertension medications. The American journal of managed care, 11, SP27-34.
[20]Wu, C.-H. (2009). Behavior-based spam detection using a hybrid method of rule-based techniques and neural networks. Expert Systems with Applications, 36(3), 4321-4330.
[21]江堉旻. (2015). 應用灰色預測法與時間序列法於連鎖藥局需求預測系統之研究. 國立台灣大學工業工程所碩士論文.[22]洪新原. (2009). 慢性病連續處方箋之成效評估-以資料探勘技術探討未開立慢性病連續處方之決定因子. 國立中正大學資訊管理研究所碩士論文
[23]劉妙珍. (2014). 影響高血壓慢箋續領之因素探討. 東海大學工業工程與經營資訊學系高階醫務工程與管理碩士在職專班碩士論文